Your browser doesn't support javascript.
loading
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
Bröckelmann, Paul J; Müller, Horst; Guhl, Teresa; Behringer, Karolin; Fuchs, Michael; Moccia, Alden A; Rank, Andreas; Soekler, Martin; Vieler, Tom; Pabst, Thomas; Baues, Christian; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas.
Afiliación
  • Bröckelmann PJ; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Müller H; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Guhl T; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Behringer K; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Fuchs M; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
  • Moccia AA; Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • Rank A; Department of Internal Medicine II, University Hospital Tuebingen, Tuebingen, Germany.
  • Soekler M; Department of Hematology and Oncology, University Hospital of Augsburg, Augsburg, Germany.
  • Vieler T; Department of Internal Medicine II, University Hospital Tuebingen, Tuebingen, Germany.
  • Pabst T; University Hospital Schleswig-Holstein, Karl Lennert-Cancer Center, Kiel, Germany.
  • Baues C; Swiss Group for Clinical Cancer Research, Bern, Switzerland.
  • von Tresckow B; Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
  • Borchmann P; Department of Radiooncology and Cyberknife Center, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Cologne, Germany.
  • Engert A; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Duesseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany.
J Clin Oncol ; 39(2): 107-115, 2021 01 10.
Article en En | MEDLINE | ID: mdl-33058716
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Alemania